Effect of Pravastatin on Myocardial Perfusion After Percutaneous Transluminal Coronary Angioplasty
Overview
Affiliations
We studied the effect of pravastatin on coronary perfusion after percutaneous transluminal coronary angioplasty. An exercise test performed within 2 weeks after percutaneous transluminal coronary angioplasty induced reversible perfusion defects in 66% of patients taking pravastatin and 64% of those taking placebo. At follow-up, the exercise test still induced reversible perfusion defects in 3% of patients taking pravastatin and 29% of those taking placebo.
Wang Y, Zhao H, Wang C, Zhang X, Tao J, Cui C Ther Clin Risk Manag. 2020; 16:95-101.
PMID: 32110027 PMC: 7038390. DOI: 10.2147/TCRM.S233512.
Padro T, Manfrini O, Bugiardini R, Canty J, Cenko E, De Luca G Cardiovasc Res. 2020; 116(4):741-755.
PMID: 32034397 PMC: 7825482. DOI: 10.1093/cvr/cvaa003.
Cerit L, Duygu H, Gulsen K, Gunsel A Neth Heart J. 2016; 25(4):258-263.
PMID: 27561280 PMC: 5355380. DOI: 10.1007/s12471-016-0883-x.
Women and Ischemic Heart Disease: Recognition, Diagnosis and Management.
Park S, Merz C Korean Circ J. 2016; 46(4):433-42.
PMID: 27482251 PMC: 4965421. DOI: 10.4070/kcj.2016.46.4.433.
Sex-Specific Disparities in Risk Factors for Coronary Heart Disease.
Rosen S, Henry S, Bond R, Pearte C, Mieres J Curr Atheroscler Rep. 2015; 17(8):49.
PMID: 26108894 DOI: 10.1007/s11883-015-0523-8.